Starr Quant Lab Desk Research

US · Recap

US Market Recap | 2026-10-06 (ET) Tuesday

Tue US Recap · 5 tables America/New_York

Machine-translated from the Chinese original. In case of any discrepancy, the Chinese version prevails.

Single-name entries

This is a reconciliation report — it carries no single-name score table. Recaps are structured around hit-rate reconciliation, theme verification and next-day outlook.

Coverage window: 2026-10-06 (Tue) 09:30–16:00 ET regular session + post-market moves through ~18:00 ET. Closing basis: individual stocks/ETFs use the official Nasdaq API 16:00 ET official close (pulled ~17:00–17:30 ET); the three major indices / Russell / VIX / Treasury yields / US dollar index are Yahoo Finance quotes (via data channel, closing basis); post-earnings moves through ~18:00 ET. Benchmark: pre-market list see 2026-10-06.md.

0. One-Line Recap

Today was risk-on: the 10Y Treasury yield fell back from 24-year-high territory to 5.27% (-4bp), oil dropped ~2%, the S&P closed +0.58% at 7,818.93 and the Nasdaq +0.45% at 27,599.79 — both record closes; but the strongest theme on the tape was not the AI compute bet from pre-market — it was power/nuclear (Google signed a 20-year power purchase agreement with Constellation; CEG +12.25% was #1 in the S&P, XLU +2.95% led all sectors) — the biggest surprise theme missed by the pre-market list; the pre-market list's core calls ("don't chase, wait for pullbacks, trade the OPCH discount") all played out, and OPCH +32.65% was the best single event payoff market-wide; VIX fell to 15.01 (-3.3%), tone bullish into tomorrow's FOMC minutes (14:00 ET) but watch for rates whipsawing back around 5.3%.

1. Market Overview

Index/Indicator 10/6 Close Change Notes
S&P 500 7,818.93 +0.58% Closed at a record high (Investopedia)
Nasdaq Composite 27,599.79 +0.45% Record close, 23rd record high of 2026
Dow Jones 51,521.28 +0.49% Intraday high 51,672
Russell 2000 2,830.30 -0.59% Small caps bucked the trend and weakened, diverging from the index records
VIX 15.01 -3.3% Lowest close since 10/2
10Y Treasury Yield 5.269% -4.2bp Monday's 5.311% was the highest since 2002; pulled back today (Schwab)
US Dollar Index (DXY) 101.85 -0.31%
  • Breadth: NYSE advancers/decliners roughly 2,530:770 (~3.3:1), broad gains; but structural divergence was clear — Russell 2000 closed lower, and only ~27% of S&P components had been trading above their 50-day moving average (Schwab); Apple + NVIDIA + Microsoft together already account for ~21% of the S&P (Yahoo Finance) — the index records are still driven by a handful of mega-caps.
  • Drivers: ① Weak September nonfarm payrolls (+29K) pulled the odds of another rate hike in October below 20%, the drag from high rates easing at the margin; ② WTI fell ~2% to around $87 (Gulf export recovery + European reserve releases), cooling fuel-inflation worries; ③ Q3 earnings expectations were revised up to nearly +30% (FactSet basis). Risk: the structural causes of higher yields (competition from corporate issuance, fiscal deficits, foreign selling) are unresolved, and 5.27% remains elevated.

2. Pre-Market List Reconciliation

Recommended List (10 Names)

Ticker Pre-Market Call Today % Change Delivered? Notes
OPCH Watch closely (arbitrage; the 12–14% discount has 8–10 points of convergence room) +32.65% ($31.00) ✅ Strong delivery Discount converged to 3.3%, 9 points in a single day — best single event payoff market-wide that day
APOG Watch closely (don't chase the +20% gap; wait for the post-call pullback) +12.17% ($40.00) ✅ Delivered Textbook gap-fill: the pre-market +20% converged to +12%, chasers trapped
NVDA Priority deep-dive (scale in at the $6T mark in tranches, don't chase) +0.14% ($239.24) ✅ Mostly delivered New intraday high $239.86 then faded; resistance at the mark matched the pre-market call
PCVX Watch closely (wait for the offering pricing; don't take it pre-market) -9.65% ($66.70) ✅ Delivered (risk control) Offering launched without pricing, selling pressure continued; "don't take it" avoided a drop
TSM Priority deep-dive (buying pullbacks beats chasing) -0.73% ($482.26) ✅ Delivered (risk control) Mild fade from highs; pre-market "don't chase" was correct; September monthly revenue on 10/8 is the next checkpoint
GMAB Watch closely (don't chase at the 94th percentile; wait for the pullback) -1.77% ($37.80) ✅ Delivered (risk control) Fell 1.8% against a -3.4% biotech tape — relatively resilient; not chasing was correct
ABBV Watch closely (defensive alternative) +0.39% Neutral Mild delivery, no standalone catalyst
PTC Watch closely (6.2% discount arbitrage, wait for approval) +0.38% ($193.00) Neutral Holding as normal, no new developments
MCK Watch only +0.67% — No standalone catalyst, staying on the sidelines
TSLA Watch only (narrative) +0.51% ($380.68) — Mild gain; still no checkpoint before the 10/21 earnings

Avoid List

Ticker Pre-Market Call Today % Change Delivered? Notes
MRK Avoid (high-volume breakdown) +1.73% ❌ Invalidated Bounced in a risk-on tape; the vaccine-mapping narrative took a back seat that day
PFE Avoid (low valuation leaves no room to short) +0.27% Barely Didn't fall; the avoid direction didn't hold that day
XOM/CVX Avoid (Brent pullback, earnings downgrades) +0.29% / +0.55% ❌ Invalidated Oil fell but the sector didn't follow; the energy avoid call was invalidated that day
Micro-cap speculative plays No participation Untracked — Liquidity-trap thesis unchanged

Hit rate: Of the core 5 names (TSM/APOG/NVDA/GMAB/OPCH), a strict "bullish direction" reading gives 3 up / 2 down; but the actual instructions given on these 5 pre-market were "don't chase / wait for pullbacks / play the discount," and all 5/5 risk-control calls were delivered, with OPCH's single-day +32.65% the strongest single payoff since the list launched. All 3 avoid calls were invalidated that day (MRK/PFE bounced, energy didn't fall) — lesson: on strong risk-on broad-rally days, avoid calls based on relative weakness tend to miss as a group; avoid logic suits choppy markets better than one-way markets.

3. Today's Theme Validation

Theme Pre-Market Strength Today Actual Leaders/Laggards Stage Verdict
Power/Nuclear (AI power supply) Not covered XLU +2.95% led all sectors, CEG +12.25% #1 in the S&P CEG (Google 20-year 3,590MW power purchase agreement, described as "the largest nuclear deal in history," unlocking $4.3 billion in investment, IBD) Main uptrend launch ❌ Biggest pre-market miss; the energy-derivative branch of the AI theme
M&A / deal catalyst S OPCH +32.65% convergence, PTC +0.38%; PSKY→SKYD deal completed OPCH best market-wide; SKYD fell 2–4% on its first day post-transfer (catalyst exhausted, flagged pre-market) Event payoff phase ✅ Correct call, strongest event line today
AI compute / semiconductors S SMH -0.22% flat close, violent internal divergence Leaders: AVGO +3.67%, AMD +2.80% (Citi price target $575→$800); laggards: INTC -3.18% (Terafab may bring in TSMC, diluting its exclusive position, MarketWatch), TSM -0.73%, MU -1.73% (memory supply concerns) High-level divergence ⚠️ Direction right, but strength and consistency vastly overestimated
Pharma clinical data A+ Biotech crashed overall: XBI -3.37%, IBB -2.34% Laggards: AVBP -46.9%, TWST -18.5%, TXG -17.6%, PCVX -9.65%; GMAB -1.77% relatively resilient, ABBV +0.39% De-bubbling ⚠️ Data delivered, but the sector was overshadowed by a second wave of selling after the Fed called out biotech valuations as too high (PharmExec/FT) — not anticipated pre-market
Earnings beat+raise A APOG +12.17%, LW (Lamb Weston) +12% Pre-market earnings names broadly opened high and converged Routine delivery ✅ Correct call

Post-mortem: Today's true leading theme was the energy derivative of AI compute (nuclear/power) and M&A events, not the compute chips themselves; pre-market put all its weight on the chip chain (rated S), but the chip chain actually saw high-level divergence that day — what outperformed were the assets "powering AI." The biotech crash was a policy narrative (Fed valuation warning) that couldn't be foreseen pre-market, but the power branch (AI capex → power gap → long-term nuclear contracts) had clues available pre-market (Goldman raised its data-center power demand forecast last week) — this was insufficient coverage.

4. Post-Earnings Moves (10/6 Post-Market, Catalysts for 10/7)

Ticker Results Guidance Post-Market (through ~18:00 ET)
PENG (Penguin Solutions, AI servers) EPS $1.00 vs $0.75 (beat by 19%); revenue $566.7M vs $512.5M, +67.7% YoY FY27 non-GAAP EPS $3.75–$5.15 (midpoint $4.45) vs consensus $3.40; revenue ~$2.43B vs $2.19B — sharply raised (StockAnalysis) Post-market direction mildly higher, exact magnitude not yet confirmable
STZ (Constellation Brands) EPS $3.74 vs $3.62; revenue $2.82B vs $2.57B (+6.1%) Reaffirmed FY27 EPS $11.20–$11.90 (GlobeNewswire) -5.31% to $110.75 (beat but sold off; call on 10/7 08:00 ET)
NEOG (Neogen) Adjusted EPS $0.09 vs ~$0.05; revenue $222.8M +6.5% Core organic +8.1% (Business Wire) +9.87% to $13.14
CRBU (Caribou, non-earnings) — Announced a strategic alternatives review and terminated two donor-derived CAR-T programs (StockTitan) Roughly -46% post-market, another biotech de-bubbling case
WS / SAR Worthington Steel reported post-market (call on 10/7 08:30 ET); Saratoga EPS $0.46 vs $0.47, slight miss — Exact figures not yet confirmable (small caps, low attention)

Also: LW (Lamb Weston), which reported pre-market, beat Q1 and raised its full year, closing +12%; RPM delivered a record Q1 but narrowed its outlook, shares under pressure (Business Wire). PCVX's $1 billion dual offering (common stock + convertible) remained unpriced as of publication; the pricing (expected within the next two days) is the single biggest event risk for the 10/7 pre-market.

5. Money and Sentiment

  • Rotation: Rate-sensitive defensives/value led (XLU +2.95%, XLY +1.20%, XLRE +1.09%, XLP +0.91%, XLI +0.87%); within tech, XLC +0.03% / SMH -0.22% lagged; biotech (XBI -3.37%) and Russell 2000 (-0.59%) fell most — a textbook "buy rate-sensitives on yield-pullback days, kill crowded highs" structure.
  • Macro assets: 10Y -4.2bp to 5.269%, TLT +0.22%, DXY -0.31%, GLD +0.70%, USO +0.65% (WTI fell but the ETF edged up — a basis difference); the oil decline was one of the core drivers of today's risk-on.
  • Sentiment: risk-on but structurally fragile — VIX 15.01 back to the lowest since 10/2, breadth 3.3:1, but the index rests on the top-3 weights (21% of the S&P) while diverging from small caps/Russell; the violent de-bubbling in biotech and micro-caps (AVBP -46.9%, CRBU -46% post-market) shows the fragility of high-valuation assets has not gone away.

6. Next-Day Outlook (10/7 Wednesday)

① Theme continuation: Power/nuclear is the strongest new theme today; after CEG's single-day +12% there is profit-taking risk, but the narrative of a Google-scale long-term contract is just getting started — the pullback is the window to watch for follow-through (VRT, CEG, GEV and other same-chain names); AI compute will likely chop around the $6T round-number mark (NVDA ~+4% away) amid high-level divergence, so chasing there is poor value; if biotech de-bubbling enters a third wave, don't catch the falling knife before XBI loses its low; OPCH's discount is down to just 3.3%, the arbitrage room nearly fully delivered — holders should consider taking profits.

② Tomorrow's calendar: 14:00 ET September FOMC minutes (the tone of the first minutes under Chair Warsh draws the most attention; hawkish wording could reverse today's yield pullback); earnings: no major pre-market names, post-market APLD (AI data centers, loss expected to widen to ~$0.25) and LEVI (EPS expected ~$0.36); PCVX offering pricing could land at any time; Thursday pre-market PEP, Friday pre-market DAL.

③ Watch closely:

  • NVDA: the $6T mark (~$250) + the options market pricing ~50% odds of reaching it by end of October — expect amplified volatility near the mark; price and volume first;
  • TSM: September monthly revenue on 10/8 (tomorrow post-market into early Thursday), Terafab talks + quiet period with no new guidance — if revenue beats again, the attack resumes;
  • CEG/VRT: the AI power chain — watch the follow-through after today's high-volume long green candle;
  • PENG: post-market beat + sharply raised guidance; a strong open would confirm AI server momentum, rippling through the SMCI/DDOG chain.

④ What to avoid: crowded high-valuation unprofitable biotech (the second wave under the Fed's valuation warning has only just begun); chasing any event stock that has already gapped up sharply (SKYD catalyst exhausted post-closing; CRBU-style pipeline-shrinking risk); adding leverage to duration assets ahead of the FOMC minutes.

⑤ Input for tomorrow's pre-market list: elevate "the energy derivative of AI capex (nuclear/power/grid equipment)" to a standalone theme with its own write-up; the pharma theme must distinguish "GMAB/ABBV with data/cash flow" from "unprofitable small-cap biotech" (the latter under systemic pressure); the M&A line is down to OPCH's tail end and PTC's long cycle, event density declining; raise macro weighting (the FOMC minutes at 14:00 ET land mid-session; the list needs a two-way plan for the 10Y at 5.3%).

⚠️ Data-fetch fault note: direct Yahoo access from this machine (yfinance and raw query1/query2 requests) was still rate-limited today (YFRateLimitError / Edge 429); the stooq historical API returned 404 across the board.

  • Channels actually used: Nasdaq official API (info endpoint, official 16:00 ET close, pulled 17:00–17:30 ET) + the kimi data-source plugin (Yahoo Finance channel, pulling ^GSPC/^DJI/^RUT/^VIX/^TNX/DX-Y.NYB daily bars).
  • Data not obtained: 10/6 whole-market turnover (exchange official basis); NYSE breadth is a media-cited figure (~3.3:1); official S&P 500 advance/decline values; no reliable source for PENG/WS/SAR post-market moves — the text flags these as "not yet confirmable" as appropriate.
  • The Nasdaq historical endpoint had not yet ingested 10/6 data at the time (1 hour after the close); individual-stock OHLC was not fetched — the text uses closing price + % change only.

⚠️ Risk warning: This recap is only post-market information organization and observation and does not constitute investment advice. Data may have timing or definitional differences; refer to company disclosures / SEC filings and do not use this directly as a trading basis.

Sources11

Every external link cited in the body, numbered in order of appearance. · 11 domains

  1. 1Investopediainvestopedia.com
  2. 2Schwabschwab.com
  3. 3Yahoo Financefinance.yahoo.com
  4. 4IBDinvestors.com
  5. 5MarketWatchmarketwatch.com
  6. 6PharmExec/FTpharmexec.com
  7. 7StockAnalysisstockanalysis.com
  8. 8GlobeNewswiresa.marketscreener.com
  9. 9Business Wirebusinesswire.com
  10. 10StockTitanstocktitan.net
  11. 11Business Wiremorningstar.com